Although such symptoms do not directly predict the disease, their frequent appearance in the years preceding the illness adds to experts’ understanding of the life-changing condition.
- September 08, 2023
Learn about our Dr. Naila Makhani during Women in Medicine Month!
- May 15, 2023
For families facing the end-of-life of a loved one with pediatric cancer, robust quality measures to benchmark what parents value most in their child’s medical care do not currently exist. A new study from Yale Cancer Center helps identify what parents prioritize for their children with advanced cancer, including alleviating the child’s symptoms and honoring the family’s goals and wishes. Researchers say the findings may help establish a patient-centered agenda for quality measurement and improvement in children with advanced, incurable cancer. The study titled, "Parent Priorities in End-of-Life Care for Children with Cancer,” was published in JAMA Network Open on May 15.
- May 09, 2023Source: Real Talk MS
This week, the National MS Society hosted the Pathways To Cures Global Summit, bringing together the best and brightest minds in MS research, the CEOs of major MS Societies, representatives from the pharmaceutical industry, and people affected by MS to update the scientific foundation of the Pathways To Cures research roadmap and set the global MS research agenda for the next 3-5 years. Dr. Naila Makhani discusses detecting MS early at the 33:54 timestamp.
- March 29, 2023Source: Medscape
Imaging tests may miss early signs of multiple sclerosis (MS) in children who have no symptoms of the disease, according to a recent study that points to the need for a change in diagnostic criteria for the neuromuscular condition.
- May 19, 2022
Student Research Day honors YSM’s MD students for their research and—with the creation last year of this unique mentorship prize—pays tribute to the faculty mentors who support them.
- January 31, 2022
Naila Makhani, MD, MPH, named Harry Weaver Neuroscience Scholar by the National Multiple Sclerosis Society
Naila Makhani, MD, MPH, has been named a Harry Weaver Neuroscience Scholar by the National Multiple Sclerosis (MS) Society, starting in July of 2022. The five-year early-career award is highly competitive and prestigious –a limited number of awards are given out by the National Multiple Sclerosis Society to highly qualified newly-independent researchers.
- September 23, 2021Source: MedPage Today
Dr. Naila Makhani and Dr. Helen Tremlett discuss emerging evidence about a possible prodromal phase of MS and differentiating it from MS risk factors.
- August 20, 2018
Naila Makhani, MD, MPH, and her colleagues are using a five-year grant from the National Institutes of Health to launch a prospective study of children will identify those with a higher risk of developing MS and the biomarkers that can aid in early diagnosis.
- October 10, 2017
By the time multiple sclerosis (MS) is diagnosed in children, it may be difficult to prevent the disabilities and relapses that come with the disease. In a new Yale School of Medicine study, researchers examined MRI brain scans to identify children at high risk of developing MS before symptoms appear, which may lead to earlier diagnosis and treatment.